kari Therapeutics announced the appointment of Mark Kubik as Head of Business Development – Oncology.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKTX:
- Akari Therapeutics releases video from newly appointed CEO Gaslightwala
- Akari Therapeutics Advances ADC Development Amid Financial Challenges
- Akari Therapeutics reports FY24 EPS 0c vs 0c last year
- Akari Therapeutics Delays Yearly Financial Report
- Akari Therapeutics Appoints New CEO Abizer Gaslightwala